Radiopharm Theranostics, Ltd
7 clinical trials · Sponsor
◉ Watch Radiopharm Theranostics, Ltd
| Record | Firm | Date |
|---|---|---|
| A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors. (NCT07272642) | Radiopharm Theranostics, Ltd | 2026-10-30 |
| A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC (NCT07259213) | Radiopharm Theranostics, Ltd | 2026-03-05 |
| 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors (NCT07189871) | Radiopharm Theranostics, Ltd | 2026-02-23 |
| HEAT Trial (HER2 Antibody Therapy With Lutetium-177) (NCT06824155) | Radiopharm Theranostics, Ltd | 2025-02-12 |
| Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases (NCT06777433) | Radiopharm Theranostics, Ltd | 2024-12-13 |
| 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors (NCT06305962) | Radiopharm Theranostics, Ltd | 2024-06-03 |
| Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors (NCT05799274) | Radiopharm Theranostics, Ltd | 2023-11-09 |
Track Radiopharm Theranostics, Ltd automatically
Every clearance here is in the API, with alerts when new ones post.